Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02999360 · ClinicalTrials.gov registry record · NA
Aerobic Exercise and Aphasia Treatment
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02999360: Completed NA study, sponsored by NYU Langone Health.
NCT02999360 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02999360, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of the study is to determine if speech therapy can be enhanced by Aerobic Exercise (AE). Investigators will use a single subject design to determine if aphasia therapy result in greater gains when combined with aerobic exercise.
Primary Outcome
Patient-reported outcome measure of communicative functioning for persons with aphasia
Interventions
- BEHAVIORAL Aerobic Exercise
- BEHAVIORAL Language therapy
- BEHAVIORAL Background Music
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2016-12-19 |
| Est. Completion | 2019-09-20 |
| Phase | NA |
What the finished NCT02999360 record still lists
NCT02999360 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Aerobic Exercise is the first listed.
NCT02999360 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02999360 about?
NCT02999360 is a clinical study titled "Aerobic Exercise and Aphasia Treatment". The purpose of the study is to determine if speech therapy can be enhanced by Aerobic Exercise (AE). Investigators will use a single subject design to determine if aphasia therapy result in greater gains when combined with aerobic exercise.
What is the current status of trial NCT02999360?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2016-12-19. Estimated completion is 2019-09-20.
What interventions are being tested in trial NCT02999360?
The interventions under investigation include: Aerobic Exercise (BEHAVIORAL), Language therapy (BEHAVIORAL), Background Music (BEHAVIORAL).
Who is sponsoring clinical trial NCT02999360?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02999360's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI